Pharm-Olam is now Allucent. Learn More

Request a Proposal  

Infectious Disease & Vaccine Solutions

Offering global Infectious Disease and Vaccine CRO services in support of clinical research for emerging and re-emerging diseases.

Our extensive experience in the conduct of trials in infectious diseases caused by viruses, bacteria, fungi or parasites, including COVID-19, provides a significant advantage in proven strategic planning, regulatory guidance, and successful clinical trial execution.

Extensive Infectious Diseases and Vaccines Expertise

It’s important to choose a team that has the right kind of therapeutic experience for your clinical trial. Pharm-Olam’s therapeutically aligned, specialized staff have a broad range of expertise in Infectious Disease and Vaccine clinical development and regulations from the US, EU, and beyond with 85% of PMs and 80% of CRAs currently on staff having worked, or are actively working in, infectious disease and vaccines trials.



COVID19 (vaccines/treatment)
C. difficile
Pneumonia (CAP, HAP, VAP)
Hepatitis B
Hepatitis C
Influenza A, B, C
Complicated Intra-abdominal infection
Complicated skin and skin structure infections
Urinary tract infection (complicated and non-complicated)
Upper respiratory tract infection
Sepsis/septic shock
Otitis media
Prosthetic joint infection
Common cold
Tinea pedis
Traveler's diarrhea

Sponsor Testimonial

“Working with Pharm-Olam was an absolute pleasure. The entire team was very knowledgeable, professional and customer focused. They showed an excellent level of organization and were always on top of any issues.”

Biotech - Director ClinOps

Global Infectious Disease & Vaccine Expertise

Vaccine Development Specialization

Our Vaccines Development experts have extensive experience designing, implementing, and executing clinical trials involving live attenuated, inactivated, subunit, toxoid, mRNA, and viral vector vaccines for infectious diseases, allergies, immunotherapies, and oncology indications including; COVID-19, Hepatitis B & C, grass, birch, and dust mite allergies, cervical cancer and melanoma.

Monitoring Strategies for Vaccine Trials

Data-driven, risk-based monitoring solutions, including centralized monitoring, designed specifically to take into account large data volume upon enrolment of vaccine trials, whilst ensuring data integrity in remote settings.

Patient Recruitment - Global, Regional, Seasonal

Natural selection of pathogens, diversity of trial participants, and timing are all important site selection criteria for infectious disease clinical trials. Our global reach, including industry-leading Central & Eastern Europe specialization, provides access to patient populations, site networks, and academic institutions, focused on meeting and exceeding your enrolment goals.

Critical Care Setting Experts

Pharm-Olam's teams have deep expertise in supporting studies in an ICU/critical care setting and navigating the common challenges encountered in this complex environment. That knowledge enables us to provide proactive and insightful CRO services based on proven strategies for indications from Pneumonia to COVID-19 and everywhere in between.

Federal Research CRO Solutions

We have supported federally-funded vaccine and infectious disease clinical research programs for more than 20 years. Our proven track record has allowed us to collaborate with multiple government agencies including NIH, DOD, BARDA, and CDC.

Regulatory Strategies & Submissions Team

Whether your new product is a drug, vaccine, biologic, GMO, cell and gene therapy, device, or a combination product, we understand the nuances of regulatory requirements and have the resources and proven expertise to address your specific needs.

Infectious Disease & Vaccine Clinical Research By The Numbers

In the past several years our teams have supported over 75 infectious diseases and vaccine trials across a variety of therapeutic areas and indications, including 14 product approvals.

Infectious Disease and
Vaccine Trials
Product Approvals

Pharm-Olam Supporting COVID-19 Research

Pharm-Olam stands with the global community in the fight against COVID-19. No other disease in recent history has captured the world like Coronavirus. As a Vaccine and Infectious Disease CRO, we are poised to help pharmaceutical and biotech’s by rapidly deploying their clinical trials in the search for vaccines and therapies to fight infectious disease. Together, we can create a healthier world.

Looking for a partner to support your infectious diseases and vaccines clinical development programs?

Our infectious disease team is ready to help. Talk with our experts today.